AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteABT-492 is a new fluoroquinolone against 155 aerobic and 171 anaerobic pathogens.
More Information Supplier PageABT-492 is a new fluoroquinolone against 155 aerobic and 171 anaerobic pathogens.
More Information Supplier PageABT-492 is a new fluoroquinolone against 155 aerobic and 171 anaerobic pathogens.
More Information Supplier PageABT-492 is a new fluoroquinolone against 155 aerobic and 171 anaerobic pathogens.
More Information Supplier PageABT-737 is a pan-Bcl-2 inhibitor. IC50 values ranged from 192 nM (the pre-B cell line Hal-01) to
More Information Supplier PageABT-737 is a pan-Bcl-2 inhibitor. IC50 values ranged from 192 nM (the pre-B cell line Hal-01) to
More Information Supplier PageABT-737 is a pan-Bcl-2 inhibitor. IC50 values ranged from 192 nM (the pre-B cell line Hal-01) to
More Information Supplier PageABT-737 is a pan-Bcl-2 inhibitor. IC50 values ranged from 192 nM (the pre-B cell line Hal-01) to
More Information Supplier PageABT-737 is a pan-Bcl-2 inhibitor. IC50 values ranged from 192 nM (the pre-B cell line Hal-01) to
More Information Supplier PageABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.
More Information Supplier PageABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.
More Information Supplier PageABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.
More Information Supplier PageABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.
More Information Supplier PageABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.
More Information Supplier PageABT-888(Veliparib) is a potential anti-cancer drug acting as a PARP inhibitor.
More Information Supplier PageABT-888(Veliparib) is a potential anti-cancer drug acting as a PARP inhibitor.
More Information Supplier PageABT-888(Veliparib) is a potential anti-cancer drug acting as a PARP inhibitor.
More Information Supplier PageABT-888(Veliparib) is a potential anti-cancer drug acting as a PARP inhibitor.
More Information Supplier PageABT-888(Veliparib) is a potential anti-cancer drug acting as a PARP inhibitor.
More Information Supplier PageAc-LEHD-AFC is a fluorogenic substrate for caspase-4, caspase-5, and caspase-9.
More Information Supplier PageAc-LEHD-AFC is a fluorogenic substrate for caspase-4, caspase-5, and caspase-9.
More Information Supplier PageAc-LEHD-AFC is a fluorogenic substrate for caspase-4, caspase-5, and caspase-9.
More Information Supplier PageAc-LEHD-AFC, fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC.
More Information Supplier PageAc-LEHD-AFC, fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC.
More Information Supplier PageAc-LEHD-AFC, fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageACA is a channel blocker that acts on several transient receptor potential (TRP) channels, including TRPM2, TRPM8, and TRPC6 (IC50 = 1.7, 3.8, and 2.3 uM, respectively).
More Information Supplier PageACA is a channel blocker that acts on several transient receptor potential (TRP) channels, including TRPM2, TRPM8, and TRPC6 (IC50 = 1.7, 3.8, and 2.3 uM, respectively).
More Information Supplier PageACA is a channel blocker that acts on several transient receptor potential (TRP) channels, including TRPM2, TRPM8, and TRPC6 (IC50 = 1.7, 3.8, and 2.3 uM, respectively).
More Information Supplier PageAcacetin is a flavonoid with anti-peroxidative and anti-inflammatory properties.
More Information Supplier PageAcacetin is a flavonoid with anti-peroxidative and anti-inflammatory properties.
More Information Supplier PageAcacetin is a flavonoid with anti-peroxidative and anti-inflammatory properties.
More Information Supplier PageAcadesine is a selective activator of AMPK in both hepatocytes and adipocytes.
More Information Supplier PageAcadesine is a selective activator of AMPK in both hepatocytes and adipocytes.
More Information Supplier PageAcadesine is a selective activator of AMPK in both hepatocytes and adipocytes.
More Information Supplier PageAcalisib is an inhibitor of the beta and delta isoforms of the 110 kDa catalytic subunit of class IA phosphoinositide-3 kinases (PI3K) with potential immunomodulating and antineoplastic activities.
More Information Supplier Page
